Marine Ingredients Market Outlook 2026-2034: by Ingredient Type (Fish Meal, Fish Oil, Krill Oil, Algal DHA/EPA Oil, Marine Collagen, Protein Hydrolysates and Peptides, Astaxanthin and Other marine Carotenoids, Others), Application, Source

The Marine Ingredients Market is estimated at US$16.1 billion in 2026 and is projected to grow at a CAGR of 6.1% to reach US$25.9 billion by 2034.

Market Overview

The marine ingredients market covers functional materials and bioactive compounds derived from fish, algae, shellfish, krill, and other marine sources for use in food, feed, nutraceutical, pharmaceutical, personal care, and industrial applications. This market includes fish oil, fish meal, marine proteins, collagen, omega rich concentrates, mineral extracts, chitosan, algae based ingredients, and specialty marine derived compounds used in animal nutrition, dietary supplements, aquaculture, cosmetics, and health related product development.

The value chain spans raw marine biomass sourcing, harvesting and aquaculture inputs, primary processing, extraction and refining, formulation, quality testing, ingredient distribution, and downstream product manufacturing. Market relevance is reinforced by expanding use of marine based compounds in both traditional feed markets and premium value added health and personal care applications.

Market Segmentation

By Ingredient Type

• Fish Meal
• Fish Oil
• Krill Oil
• Algal DHA/EPA Oil
• Marine Collagen
• Protein Hydrolysates and Peptides
• Astaxanthin and Other marine Carotenoids
• Others

By Application

• Aquaculture Feed
• Animal Nutrition & Pet Food
• Dietary Supplements
• Functional Foods & Beverages
• Pharmaceuticals
• Cosmetics & Personal Care
• Fertilizers & Agriculture Biostimulants

By Source

• Fish
• Krill
• Squid
• Seaweed
• MicroAlgae

Key Companies Analysed

• DSM-Firmenich
• Omega Protein
• Pelagia
• TripleNine
• GC Rieber
• FF Skagen
• Biomega
• Corbion
• Cargill
• Skretting
• Mowi Feed
• BioMar
• Archer Daniels Midland
• BASF
• IFFO members
• Aker BioMarine
• EPAX
• Croda
• Golden Omega
• KD Pharma

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.